Record overview
Status and phase
Status: TERMINATED
Phase: PHASE2
Sponsor: Pfizer
Condition: Carcinoma, Non-Small-Cell Lung
NCT00313768
Randomized Ph 2 Trial Of Paclitaxel/Carboplatin /Bevacizumab + PF-3512676 And P/C/B Alone In Advanced Nonsquamous NSCLC
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Registry Stop Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: rare_population_signal | strict_eligibility_signal
Stopped reason
Context when available
See Termination Reason in Detailed Description.